Notably, in colon cancer, MKP-1 was overexpressed in the early phases of carcinogenesis [22] and impaired the response to cetuximab-based treatment in metastatic colon cancer patients [23]. This evidence concerns the gene DUSP1 and malignant colon neoplasm.